Shareholder alert: ademi llp investigates whether albireo pharma, inc. has obtained a fair price in its transaction with ipsen

Milwaukee , jan. 9, 2023 /prnewswire/ -- ademi llp is investigating albireo (nasdaq: albo) for possible breaches of fiduciary duty and other violations of law in its transaction with ipsen.  click here to learn how to join the action https://www.ademilaw.com/case/albireo-pharma-inc or call guri ademi toll-free at 866-264-3995.
ALBO Ratings Summary
ALBO Quant Ranking